Heartflow, Inc. officer Campbell D. Rogers filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 24,188 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.

Key Highlights

  • Proposed sale size: 24,188 shares of Heartflow, Inc. common stock, with an aggregate market value of $1,122,081.32.
  • Shares outstanding: The filing states 87,887,561 shares of common stock outstanding at the approximate date of sale.
  • Acquisition sources: The shares to be sold were acquired via a stock option exercise on 03/01/2021 (6,503 shares), restricted stock vesting on 11/07/2025 (256 shares), and a stock option exercise on 11/17/2026 (17,429 shares), all from the issuer.
  • Related-party trusts: The filing notes that today's trade includes 6,503 shares from the Sarah Rogers 2020 Irrevocable Trust, of which Campbell D. Rogers is a trustee and account stakeholder.
  • Rule 10b5-1 plan: The filing indicates a plan adoption date of 06/16/2026.
  • Prior three-month sales: Sales in the prior three months by Rogers and related trusts totaled 64,141 shares across seven transactions, with gross proceeds including $380,099.37 (08/17/2026), $660,926.85 (09/18/2026), $283,497.95 (09/18/2026), $326,125.45 (09/18/2026), $958,824.30 (10/22/2026), $311,026.54 (10/22/2026), and $357,730.03 (10/22/2026).

Heartflow Officer Rogers Discloses Proposed Common Stock Sale Under Rule 144

According to the Form 144 filing, Campbell D. Rogers, identified as an officer of Heartflow, Inc. (NASDAQ:HTFL), proposed to sell 24,188 shares of the company's common stock through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The filing lists an approximate sale date of 11/17/2026 and an aggregate market value of $1,122,081.32 for the proposed sale. The filing states that 87,887,561 shares of common stock were outstanding at that date.

The filing discloses three separate acquisition lots underlying the shares to be sold. A total of 6,503 shares were acquired through a stock option exercise on 03/01/2021, paid in cash. An additional 256 shares vested from restricted stock on 11/07/2025 as compensation. The remaining 17,429 shares were acquired through a stock option exercise on 11/17/2026, also paid in cash. All acquisitions were from the issuer.

The remarks section of the filing states: "Today's trade includes 6,503 shares sold from the Sarah Rogers 2020 Irrevocable Trust of which Campbell D. Rogers is a trustee and account stakeholder. Sales from the past 3 months also include sales from this account as well as the Sarah Rogers Ttee Campbell Rogers 2019 Irrevocable Trust, of whom Sarah D. Rogers is a trustee and the spouse of Campbell D. Rogers, an officer in the company." The filing reports a Rule 10b5-1 plan adoption date of 06/16/2026. The notice was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Campbell D. Rogers.

What Was Disclosed

Heartflow, Inc. officer Campbell D. Rogers filed a Form 144 notice proposing to sell 24,188 shares of common stock with an aggregate market value of $1,122,081.32 on NASDAQ on November 17, 2026, under a Rule 10b5-1 plan adopted on June 16, 2026.